PrefHer: finally addressing the preferences of her, too

Lancet Oncol. 2013 Sep;14(10):914-5. doi: 10.1016/S1470-2045(13)70389-9. Epub 2013 Aug 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Receptor, ErbB-2 / analysis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab